Skip to main content

Digital support for paediatric obesity care

Obesity doesn't stop between visits

Evira is a digital support for combined lifestyle treatment in childhood obesity. Care teams monitor development and maintain treatment contact between clinic visits.

Evira has been used in clinical practice since 2018

Så här används Evira idag

treatment centres

48

treatment centres

countries

6

countries

clinics in the UK

16

clinics in the UK

Swedish regions

6

Swedish regions

Läs om hur vårdgivare använder Evira i klinisk praktik

Clinical effect

Twice as good as conventional treatment

Evira improves care by strengthening the alliance with the family, offering rapid feedback, and doubling the results after one year, with a lasting effect after three years.

0−0,10−0,20−0,30Home6 months1 year3 yearsChange in BMI SDS−0.15 conventional treatmentcomparison against the quality register BORIS−0.30 BMI SDSthe effect was maintained for up to three years
Evira as an addition to combined lifestyle treatment delivered −0.30 BMI SDS after twelve months, versus −0.15 for conventional treatment according to the quality register BORIS. The effect was maintained for up to three years.
  • −0.30 BMI SDS

    Better weight development after one year than standard treatment (−0.15)

    Pragmatic clinical study with comparison to the quality register BORIS, International Journal of Obesity 2022.

    See the study
  • 3 years

    Effect maintained for up to three years, with significantly fewer dropouts

    Follow-up of the same cohort, 428 patients, International Journal of Obesity 2025.

    See the follow-up
  • 48 behandlingscenter

    Used in clinical practice in six countries since 2018

    16 clinics in the UK and 6 Swedish regions currently use Evira.

    Read customer case studies

Workflow and workload

How the Evira method works in clinical practice

Combined lifestyle treatment together with Evira enables long-term follow-up and close contact between visits.

  1. 1. Treatment goals are set together

    The family

    The family is the expert on their own situation and describes what is possible to change in daily life.

    The healthcare provider

    The healthcare provider is responsible for the treatment and sets an individual goal for weight development in Evira.

  2. 2. Home measurement

    The family

    The family measures regularly with the measuring plate – a connected scale that shows no numbers.

    The healthcare provider

    The healthcare provider receives high-resolution measurement data in the web interface, with individual height estimation per patient.

  1. 3. The trend is followed between visits

    The family

    The app shows relative weight development towards the goal, so the family sees the results of their own efforts directly.

    The healthcare provider

    The healthcare provider sees which patients deviate from their trend and can prioritise those who need more support.

  2. 4. Support when needed

    The family

    The family can ask questions in the app when they need to and receive feedback without waiting for the next visit.

    The healthcare provider

    The healthcare provider acts proactively when a positive trend is broken, instead of discovering it retrospectively.

The family working from home in everyday lifeThe healthcare provider monitors and guides the treatment

The cycle is repeated between visits. Visits every 3–6 months.

The entire treatment flow step by step

Clinical everyday life with Evira

Responsibility

The healthcare provider is responsible for assessment, treatment, and documentation. Evira is a support in that treatment, not an independent healthcare provider.

Working method

The team works in the web interface between appointments: monitoring trends, answering questions, and prioritising families who deviate from their goal.

Resources

Follow-up is consolidated rather than appointment by appointment, meaning more families can receive close contact within existing staffing levels.

Evidence

Evira supports the treatment that is already recommended

Combined lifestyle treatment (KLB) is the basis of all childhood obesity treatment and aims for healthy weight development. According to the care programme, KLB should be individualised and age-adapted, structured, long-term, and evidence-based, and can be carried out through physical visits or remotely, individually or in groups.

The care programme describes that the intensity of the treatment is crucial for the outcome and that the treatment needs to correspond to at least 26 hours per year. Maintaining regular treatment contact is also described as a challenge.

The care programme describes digital treatment support as developed to complement physical visits, with a greater ability to maintain close treatment contact with the family. To use them, a clear agreement is required to manage costs, personal data, care responsibility, and patient data.

National care programme for the treatment of obesity in children and adolescents (2023-05-15)

The care programme and KLB in its entirety

Documented effect according to the care programme

The care programme compiles documented effects for treatment interventions with a minimum treatment period of 12 months, measured by change in BMI SDS. Evira is included in the compilation.

−0,30

BMI SDS

Evira + combined lifestyle treatment

4–18 years · 107 children · at least 12 months of treatment

  • Combined lifestyle intervention

    −0,13 till −0,15

  • Intensiv kombinerad levnadsvanebehandling

    −0,17 till −0,30

  • Evira + combined lifestyle treatment

    −0,30

The results are from different studies with different populations and study designs and should not be interpreted as a direct comparative study between treatment methods.

Usage and acceptance

Evira is used here today

Evira is used in paediatric clinics and child and adolescent medical clinics in Sweden, as well as in specialist clinics in the UK that treat complications from excess weight (CEW). Evira is also used in clinical research in several European countries.

United Kingdom – CEW clinics

The British clinics are CEW (Complications from Excess Weight) clinics – NHS specialist clinics for children and young people with obesity and its associated diseases. Read more at NHS England.

Voices from families and healthcare providers

“For the family, it hasn’t been about staring blindly at weight in kilos, but rather understanding trends, learning about portions, and gaining motivation through positive feedback from responsible healthcare providers.”
Maya, mother of a 10-year-old girl treated with Evira for about 3 years.
"We are glad that we started using Evira at our clinic. It brings life to the treatment! To be able to give continuous support and notice both negative and positive trends in time. Finally, we can work proactively with this patient group!"
Childhood obesity team, Östersund

Safety and responsibility

Safety and patient data

Evira is a CE-marked medical device in Class I according to MDR. Patient data is processed within the EU, with data processing agreements and information security work according to healthcare requirements.

Security and patient data in detail

Next step

Implementation at the clinic

Implementation takes place incrementally, with clear division of responsibility and training before the first families start.

  1. 01

    Review

    We review the treatment flow and your current healthcare process.

  2. 02

    Agreement and data management

    Personal data processor agreement and information security in place.

  3. 03

    Team training

    The treating staff are trained in the method and the web interface.

  4. 04

    First patients

    You start with a small number of families and then scale up.

How an implementation works

Would you like to see how Evira would work at your clinic?

We'll go through the treatment flow, the requirements of the care programme, and what an implementation entails for your team.

Fields marked with * are required.